Rapid improvement of rubeosis iridis from a single bevacizumab (Avastin) injection

Retina. 2006 Mar;26(3):354-6. doi: 10.1097/00006982-200603000-00017.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Choroid Neoplasms / pathology
  • Fluorescein Angiography
  • Fluorophotometry
  • Glaucoma, Neovascular / diagnosis
  • Glaucoma, Neovascular / drug therapy*
  • Humans
  • Injections
  • Iris / blood supply*
  • Iris / pathology
  • Iris Diseases / diagnosis
  • Iris Diseases / drug therapy*
  • Male
  • Melanoma / pathology
  • Middle Aged
  • Vascular Endothelial Growth Factor A / immunology
  • Visual Acuity
  • Vitreous Body

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Bevacizumab